<div id="readability-page-1"><p><span>Blue Bird (NASDAQ:BLBD - Get Free Report)</span> was downgraded by stock analysts at Zacks Research from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research report issued to clients and investors on Monday,Zacks.com reports.</p><ul><li>Top 3 High-Risk, High-Reward Plays for Bullish Investors</li></ul><p>A number of other analysts also recently commented on BLBD. Wall Street Zen downgraded Blue Bird from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, February 7th. Needham &amp; Company LLC upped their price objective on Blue Bird from $78.00 to $86.00 and gave the company a &#34;buy&#34; rating in a research report on Thursday, May 7th. BTIG Research increased their target price on Blue Bird from $65.00 to $80.00 and gave the stock a &#34;buy&#34; rating in a research report on Thursday, May 7th. Freedom Capital downgraded Blue Bird from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, May 7th. Finally, Barclays upped their price target on Blue Bird from $55.00 to $75.00 and gave the stock an &#34;overweight&#34; rating in a research note on Thursday, May 7th. Six equities research analysts have rated the stock with a Buy rating, one  has given a Hold rating and one  has assigned  a Sell rating to the company's stock. Based on data from MarketBeat, the stock  has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $75.80.</p><p><b>View Our Latest Stock Analysis on Blue Bird</b></p><h2>Blue Bird Trading Down 1.5%</h2><ul><li>Is CRISPR Therapeutics the NVIDIA of gene editing?</li></ul><p>NASDAQ:BLBD opened at $69.33 on Monday. The firm has a market cap of $2.19 billion, a P/E ratio of 17.03, a PEG ratio of 0.99 and a beta of 1.38. The company has a current ratio of 1.83, a quick ratio of 1.27 and a debt-to-equity ratio of 0.28. The stock's 50 day simple moving average is $59.72 and its 200-day simple moving average is $54.84. Blue Bird has a 12-month low of $37.68 and a 12-month high of $81.51. </p><p>Blue Bird (NASDAQ:BLBD - Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $1.00 earnings per share for the quarter, topping analysts' consensus estimates of $0.88 by $0.12. Blue Bird had a return on equity of 53.68% and a net margin of 8.91%.The firm had revenue of $352.64 million for the quarter, compared to analyst estimates of $335.23 million. During the same quarter in the prior year, the company posted $0.96 earnings per share. Blue Bird's quarterly revenue was down 1.7% on a year-over-year basis.  Equities analysts anticipate that  Blue Bird will post 4.35 EPS for the current year. </p><h2>Insider Buying and Selling</h2><ul><li>Gene therapy: Why does it cost millions for a single treatment? </li></ul><p>In other news, CFO Razvan Radulescu sold 3,925 shares of Blue Bird stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $60.98, for a total value of $239,346.50. Following the completion of the transaction, the chief financial officer owned 42,255 shares in the company, valued at approximately $2,576,709.90. This trade represents a 8.50% decrease in their position. The sale was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through the SEC website. Also, COO Jeffrey Scott Sanfrey sold 5,192 shares of Blue Bird stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $58.54, for a total value of $303,939.68. Following the completion of the transaction, the chief operating officer owned 39,011 shares of the company's stock, valued at approximately $2,283,703.94. The trade was a 11.75% decrease in their position. The SEC filing for this sale provides additional information. 1.10% of the stock is owned by company insiders. </p><h2>Institutional Inflows and Outflows</h2><p>Hedge funds have recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd lifted its holdings in shares of  Blue Bird by 10,028.6% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 709 shares of the company's stock worth $41,000 after purchasing an additional 702 shares during the last quarter.  Rockefeller Capital Management L.P. raised its stake in  Blue Bird by 210.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 775 shares of the company's stock valued at $36,000 after acquiring an additional 525 shares in the last quarter.  Transamerica Financial Advisors LLC raised its stake in  Blue Bird by 222.7% during the 4th quarter. Transamerica Financial Advisors LLC now owns 823 shares of the company's stock valued at $39,000 after acquiring an additional 568 shares in the last quarter.  Aster Capital Management DIFC Ltd acquired a new position in shares of  Blue Bird during the 4th quarter valued at $41,000.  Finally, Larson Financial Group LLC increased its position in shares of  Blue Bird by 1,742.3% during the 3rd quarter. Larson Financial Group LLC now owns 1,308 shares of the company's stock valued at $75,000 after purchasing an additional 1,237 shares during the period. Institutional investors and hedge funds own  93.59% of the company's stock. </p><h2>Blue Bird Company Profile</h2> (Get Free Report)<p>Blue Bird Corporation <span>NASDAQ: BLBD<span></span></span> is a leading manufacturer of buses and mass transportation vehicles headquartered in Fort Valley, Georgia. The company's core business encompasses the design, engineering, and production of school buses and activity buses, with a product lineup that includes conventional (Type C) models, transit-style (Type D) models and specialty configurations for special-needs and activity transport. In recent years, Blue Bird has expanded its offerings to include zero-emission electric school buses, reflecting its commitment to advanced propulsion technologies and environmental sustainability.  </p><p>Established in 1927, Blue Bird has built a legacy of safety and reliability in student transportation.</p><h2>See Also</h2><ul><li>Five stocks we like better than Blue Bird</li><li>Navy Catalyst Ignites Odysight’s Growth Engine</li><li>AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?</li><li>Axon Surged After Earnings and Is Still Down Over 50% From Highs</li><li>The Event That Could Redefine Apple’s Summer Rally</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QkxCRA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Blue Bird Right Now?</h2><p>Before you consider Blue Bird, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blue Bird wasn't on the list.</p><p>While Blue Bird currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

BLBD

<p>Zacks Research downgraded Blue Bird (NASDAQ:BLBD) from a "hold" to a "strong sell" rating. Other analysts have also adjusted their ratings, with Wall Street Zen downgrading it to "buy" and Needham & Company raising the price target to $86. Blue Bird's stock has a consensus rating of "Moderate Buy" and a target price of $75.80. The stock opened at $69.33, with a market cap of $2.19 billion. Recent insider sales were reported, and hedge funds have increased their positions in the company.</p>

Blue Bird (NASDAQ:BLBD) Cut to "Strong Sell" at Zacks Research